An international team of researchers has uncovered a promising new avenue for treating colorectal cancer, the world's third ...

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

An international team of scientists has unveiled the most comprehensive model yet that explains how cells control the flow of ...

Renal cell carcinoma (RCC) is one of the 10 most commonly diagnosed solid tumors. Most RCCs are histologically defined as clear cell, comprising approximately 75% of diagnoses. However, the remaining ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...

September is Sickle Cell Awareness Month, highlighting the need for blood donations for those with the disease. Sickle cell disease is a genetic disorder causing red blood cells to block blood flow, ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies ...

September is Sickle Cell Awareness Month — a time to recognize the strength of those living with sickle cell disease and to raise awareness about the critical role blood donations play in their care.